JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M707660200 on November 14, 2007

J. Biol. Chem., Vol. 283, Issue 3, 1508-1517, January 18, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/3/1508    most recent
M707660200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakai, H.
Right arrow Articles by Tsuchida, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakai, H.
Right arrow Articles by Tsuchida, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion Barrier*

Hiromi Sakai{ddagger}, Atsushi Sato§, Kaoru Masuda, Shinji Takeoka§1, and Eishun Tsuchida{ddagger}2

From the {ddagger}Research Institute for Science and Engineering and §Graduate School of Advanced Science and Engineering, Waseda University, Tokyo 169-8555, Japan and Kobelco Research Institute, Inc., Kobe 651-2271, Japan

One physiological significance of the red blood cell (RBC) structure is that NO binding of Hb is retarded by encapsulation with the cell membrane. To clarify the mechanism, we analyzed Hb-vesicles (HbVs) with different intracellular Hb concentrations, [Hb]in, and different particle sizes using stopped-flow spectrophotometry. The apparent NO binding rate constant, Formula, of HbV at [Hb]in = 1 g/dl was 2.6 x 107 M-1 s-1, which was almost equal to kon(NO) of molecular Hb, indicating that the lipid membrane presents no obstacle for NO binding. With increasing [Hb]in to 35 g/dl, Formula decreased to 0.9 x 107 M-1 s-1, which was further decreased to 0.5 x 107 M-1 s-1 with enlarging particle diameter from 265 to 452 nm. For CO binding, which is intrinsically much slower than NO binding, Formula did not change greatly with [Hb]in and the particle diameter. Results obtained using diffusion simulations coupled with elementary binding reactions concur with these tendencies and clarify that NO is trapped rapidly by Hb from the interior surface region to the core of HbV at a high [Hb]in, retarding NO diffusion toward the core of HbV. In contrast, slow CO binding allows time for further CO-diffusion to the core. Simulations extrapolated to larger particles (8 µm) showing retardation even for CO binding. The obtained Formula and Formula yield values similar to those reported for RBCs. In summary, the intracellular, not extracellular, diffusion barrier is predominant due to the rapid NO binding that induces a rapid sink of NO from the interior surface to the core, retarding further NO diffusion and binding.


Received for publication, September 12, 2007 , and in revised form, November 13, 2007.

* This work was supported in part by Health and Labor Sciences Research Grants (Research on Regulatory Science of Pharmaceuticals and Medical Devices), Ministry of Health, Labor, and Welfare, Japan (to H. S. and E. T.) and by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science B16300162 (to H. S.) and 18500368 (to S. T.), and Global COE "Practical Chemical Wisdom" (to S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Present address: Consolidated Research Institute for Advanced Science and Medical Care, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan.

2 To whom correspondence should be addressed: Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku, Tokyo 169-8555, Japan. Tel.: 81-3-5286-3120; Fax: 81-3-3205-4740; E-mail: eishun{at}waseda.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.